30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

David Hung

Insider profile

Currently holds positions in Establishment Labs Holdings Inc and Novocure Ltd

Performance

Overall performance
3.6

Performance over holding periods
3.6
30 days 90 days 120 days
Average return 33% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
8 38% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Establishment Labs Holdings Inc Jan. 1, 2016 -
Independent Director Novocure Ltd May 31, 2018 -
Chief Executive Officer, Director Axovant Gene Therapies Ltd April 7, 2017 - Feb. 12, 2018
President, Chief Executive Officer, Director Medivation Inc Dec. 17, 2004 - Sept. 28, 2016

David Hung's trades of Novocure Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-03 2026-06-02 S Sale
41,037 +9.9%
337.14
US$4,005,944
41,037 +9.9% 337.14 US$4,005,944
2025-06-18 2025-06-16 B Purchase
95,404 -43.8%
268.79
US$4,213,437
95,404 -43.8% 268.79 US$4,213,437
2025-06-04 2025-06-03 S Sale
22,261 -41.9%
453.60
US$1,779,989
22,261 -41.9% 453.60 US$1,779,989
2025-04-08 2025-04-07 B Purchase
300,000 +0.5%
1.63
US$487,500
300,000 +0.5% 1.63 US$487,500
2025-04-08 2025-04-04 B Purchase
200,000 +0.3%
1.66
US$332,720
200,000 +0.3% 1.66 US$332,720
2009-09-10 2009-09-10 S Sale
20,200 -100.0%
4.18
US$84,436
20,200 -100.0% 4.18 US$84,436
2009-08-27 2009-08-26 S Sale
6,800 -25.2%
1.53
US$10,404
6,800 -25.2% 1.53 US$10,404
2009-08-27 2009-08-25 S Sale
20,000 -42.6%
1.43
US$28,600
20,000 -42.6% 1.43 US$28,600
2009-08-21 2009-08-20 S Sale
5 -0.0%
1.60
US$8
5 -0.0% 1.60 US$8